Results
|
|
1801.
|
|
|
|
1802.
|
|
|
|
1803.
|
|
|
|
1804.
|
|
|
|
1805.
|
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. [electronic resource] by
- Gold, Julian
- Marta, Monica
- Meier, Ute C
- Christensen, Tove
- Miller, David
- Altmann, Daniel
- Holden, David
- Bianchi, Lucia
- Adiutori, Rocco
- MacManus, David
- Yousry, Tarek
- Schmierer, Klaus
- Turner, Benjamin
- Giovannoni, Gavin
Producer: 20181126
In:
Multiple sclerosis and related disorders vol. 24
Availability: No items available.
|
|
|
1806.
|
|
|
|
1807.
|
|
|
|
1808.
|
|
|
|
1809.
|
|
|
|
1810.
|
|
|
|
1811.
|
|
|
|
1812.
|
|
|
|
1813.
|
|
|
|
1814.
|
|
|
|
1815.
|
|
|
|
1816.
|
|
|
|
1817.
|
|
|
|
1818.
|
|
|
|
1819.
|
|
|
|
1820.
|
|